Curing cancer with Cannabidiol?
- CANNABIS OIL, NEWS
- April 24, 2013

Nordic Health Group BV (Nordic Oil), the popular European CBD manufacturer, has launched its equity crowdfunding campaign on Seedrs, a UK-based crowdfunding platform. Running throughout July, the campaign marks the first time Nordic Oil has taken in external investments in its three year history. With this milestone campaign, the company aims to generate funds that
READ MORE
Three years after Oklahoma voters approved medical marijuana, the state has 369,247 patients licensed by the Oklahoma Medical Marijuana Authority, and 11,636 businesses with an active license. More than 2,200 caregivers are licensed. State Question 788, which was approved June 26, 2018, by 57% of the voters, legalized marijuana for any medical use on a
READ MORE
A Perth firm that makes products from cannabis extracts has applied to join the stock exchange as it prepares to open its first store in Fife next month. Voyager, based at King James Business Centre, sells oils, soaps and ‘gummies’ made with cannabis extracts. The company has applied to join the Aquis Stock Exchange. Chief executive
READ MORE
The majority of cannabis patients do not consider their primary care physicians a good source of information regarding cannabis, according to a recent survey. The results coincide with a growing concern about the lack of education doctors receive regarding the therapeutic benefits cannabinoids provide. A 2020 study published in the Journal of Primary Care &
READ MORE
SAN LUIS OBISPO, Calif., June 16, 2021 /PRNewswire/ — Emerald Scientific, LLC has been accepted as an Industry Collaborator by the Consortium for Medical Marijuana Clinical Outcomes. Established in June 2019, the Consortium conducts, shares, and supports research on the effects of medical marijuana on health conditions and symptoms. Directed by a leadership team at
READ MORE
Doctors are slowly enrolling patients in France’s first experiment with medical cannabis, three months after it began. Many are eager to access the drug to address a range of disorders, including chronic pain, but participation in the experiment is onerous – and chances of success, for most, are slim. “Patients are really eager to get
READ MORE